Doshi, Peter2021-12-162021-12-162021-08-23http://hdl.handle.net/10713/17406he FDA should demand adequate, controlled studies with long term follow up, and make data publicly available, before granting full approval to covid-19 vaccines, says Peter Doshien-USCOVID-19Does the FDA think these data justify the first full approval of a covid-19 vaccine?Blog